Idoxifene's Effect on Breast Cancer Growth
Author Information
Author(s): SRD Johnston, S Riddler, BP Haynes, R A'Hern, IE Smith, M Jarman, M Dowsett
Primary Institution: Royal Marsden Hospital
Hypothesis
Does idoxifene inhibit the growth of MCF-7 breast cancer xenografts and reduce acquired anti-oestrogen resistance compared to tamoxifen?
Conclusion
Idoxifene is more effective than tamoxifen in inhibiting the growth of MCF-7 breast cancer xenografts and may reduce the development of acquired resistance.
Supporting Evidence
- Idoxifene treatment resulted in significantly lower tumor volumes compared to tamoxifen.
- None of the tumors treated with idoxifene developed acquired resistance during the study period.
- Idoxifene was more effective than tamoxifen at inhibiting MCF-7 cell growth.
Takeaway
Idoxifene helps stop breast cancer from growing better than tamoxifen and might help prevent the cancer from becoming resistant to treatment.
Methodology
The study involved establishing MCF-7 breast cancer xenografts in mice and comparing the effects of idoxifene and tamoxifen on tumor growth over six months.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Ovariectomized athymic nude mice were used in the study.
Statistical Information
P-Value
0.01
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website